113 related articles for article (PubMed ID: 4008166)
1. In vivo kinetics and thrombus accumulation of 67Ga-labeled urokinase.
Ohmomo Y; Yokoyama A; Yamauchi Y; Horiuchi K; Saji H; Tanaka C; Torizuka K
Int J Nucl Med Biol; 1985; 12(1):47-52. PubMed ID: 4008166
[TBL] [Abstract][Full Text] [Related]
2. 67 Ga-labeled human fibrinogen: a new promising thrombus imaging agent.
Ohmomo Y; Yokoyama A; Suzuki J; Tanaka H; Yamamoto K; Horiuchi K; Ishii Y; Torizuka K
Eur J Nucl Med; 1982; 7(10):458-61. PubMed ID: 7140780
[TBL] [Abstract][Full Text] [Related]
3. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
Vera DR
J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
[TBL] [Abstract][Full Text] [Related]
4. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
Mathias CJ; Wang S; Lee RJ; Waters DJ; Low PS; Green MA
J Nucl Med; 1996 Jun; 37(6):1003-8. PubMed ID: 8683292
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging.
Wang S; Lee RJ; Mathias CJ; Green MA; Low PS
Bioconjug Chem; 1996; 7(1):56-62. PubMed ID: 8741991
[TBL] [Abstract][Full Text] [Related]
6. Development of Ga-67 labeled DFO-DAS-fibrinogen conjugate as a thrombus imaging agent.
Yamaoka S
Radiat Med; 1987; 5(5):151-3. PubMed ID: 3438481
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of Ga-67 DFO-DAS-fibrinogen.
Itoh K; Tsukamoto E; Saito C; Oguma Y; Furudate M
Radiat Med; 1987; 5(5):165-9. PubMed ID: 3438485
[TBL] [Abstract][Full Text] [Related]
8. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication.
Yokoyama A; Ohmomo Y; Horiuchi K; Saji H; Tanaka H; Yamamoto K; Ishii Y; Torizuka K
J Nucl Med; 1982 Oct; 23(10):909-14. PubMed ID: 7119886
[TBL] [Abstract][Full Text] [Related]
9. Clinical applications of Ga-67 DFO-DAS-fibrinogen.
Sasaki Y; Inoue T; Noguchi M; Kawamura Y; Uchida K; Watanuki T
Radiat Med; 1987; 5(5):170-4. PubMed ID: 3438486
[TBL] [Abstract][Full Text] [Related]
10. Positive imaging of venous thrombi and thromboemboli with Ga-67 DFO-DAS-fibrinogen.
Yamamoto K; Senda M; Fujita T; Kumada K; Fukui K; Yonekura Y; Yokoyama A; Torizuka K
Eur J Nucl Med; 1988; 14(2):60-4. PubMed ID: 3391213
[TBL] [Abstract][Full Text] [Related]
11. Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase.
Ueno T; Kobayashi N; Maekawa T
Thromb Haemost; 1979 Oct; 42(3):885-94. PubMed ID: 505403
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of thrombus scintigraphy using 67Ga-deferoxamine-dialdehydestarch-fibrinogen in patients with internal A-V shunt].
Yamazaki J; Uchi T; Kawamura Y; Iida M; Hachiya Y; Matsuzaki K; Morishita T; Obara T; Hirata K; Noguchi M
Radioisotopes; 1990 Jun; 39(6):268-71. PubMed ID: 2396020
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the thrombolytic efficacy of defibrase and urokinase on canine coronary artery thrombosis and the mechanism of urokinase-induced hemorrhage.
Huang DX; Song A; Yang X; Wang S
Acta Cardiol; 1987; 42(4):249-61. PubMed ID: 3499037
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of Ga-67 DFO-DAS-fibrinogen.
Yamamoto K; Torizuka K
Radiat Med; 1987; 5(5):180-2. PubMed ID: 3438488
[TBL] [Abstract][Full Text] [Related]
15. Preparation of 67Ga-labeled antibodies using deferoxamine as a bifunctional chelate. An improved method.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Ohmomo Y; Arano Y; Yokoyama A
J Immunol Methods; 1987 Nov; 104(1-2):93-102. PubMed ID: 3316401
[TBL] [Abstract][Full Text] [Related]
16. Elimination of free radionuclide by a chelating agent improves tumor-to-nontumor ratios following radioimmunotargeting with antibody labeled with 67Ga.
Ryser JE; Rose K; Jones R; Pelegrin A; Donath A; Egeli R; Smith A; Offord RE
Nucl Med Biol; 1998 Apr; 25(3):261-5. PubMed ID: 9620632
[TBL] [Abstract][Full Text] [Related]
17. Antibody-based PET of uPA/uPAR signaling with broad applicability for cancer imaging.
Yang D; Severin GW; Dougherty CA; Lombardi R; Chen D; Van Dort ME; Barnhart TE; Ross BD; Mazar AP; Hong H
Oncotarget; 2016 Nov; 7(45):73912-73924. PubMed ID: 27729618
[TBL] [Abstract][Full Text] [Related]
18. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
[TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts.
Mathias CJ; Wang S; Low PS; Waters DJ; Green MA
Nucl Med Biol; 1999 Jan; 26(1):23-5. PubMed ID: 10096497
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-citrate versus 67Ga-citrate for the scintigraphic visualization of inflammatory lesions.
Ercan MT; Aras T; Unlenen E; Unlü M; Unsal IS; Hasçelik Z
Nucl Med Biol; 1993 Oct; 20(7):881-7. PubMed ID: 8242001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
